Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 11/20 | 0.60 |
| ▸ | CCKAR | P32238 | 2/20 | 0.59 |
| ▸ | NMBR | P28336 | 1/20 | 0.59 |
| ▸ | GRPR | P30550 | 1/20 | 0.59 |
| ▸ | GLP1R | P43220 | 3/20 | 0.59 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.57 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29410419 | 0.98 | GLP1R (0.61) | CCKBRCCKARNMBRGRPRGLP1R | |
| SCHEMBL29389409 | 0.92 | IL23R (0.64) | CCKBRCCKARIL23R | |
| SCHEMBL30037155 | 0.90 | IL23R (0.62) | CCKBRCCKARGLP1RIL23R | |
| SCHEMBL29410268 | 0.90 | IL23R (0.62) | CCKBRCCKARGLP1RIL23R | |
| SCHEMBL29389186 | 0.90 | IL23R (0.62) | CCKBRCCKARGLP1RIL23R | |
| SCHEMBL29534029 | 0.89 | IL23R (0.61) | CCKBRCCKARGLP1RIL23R | |
| SCHEMBL30037407 | 0.89 | IL23R (0.61) | CCKBRCCKARGLP1RIL23R | |
| SCHEMBL29702143 | 0.87 | CCKBR (0.74) | CCKBRCCKARGRPR | |
| SCHEMBL29408675 | 0.86 | CCKBR (0.74) | CCKBRCCKARGRPR | |
| SCHEMBL30999638 | 0.86 | CCKBR (0.64) | CCKBRCCKARGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | CCKBR 257/4885CCKAR 194/4885NMBR 224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.